1. Tamura, A. Major bleeding in a patient with warfarin-hypersensitive and factor IX propeptide variant, p.Ala37Thr, who was treated with a direct oral anti-Xa inhibitor. Ann Hematol.in press.
2. Kondo, M. Case of Scedosporium aurantiacum infection detected in a subcutaneous abscess. Medical Mycology Case Reports,in press.
3. Kondo, M. Comparison of positive ratio for red meat-specific immunoglobulin E between endemic and non-endemic area for Japanese spotted fever in Mie Prefecture, Japan. J Dermatol,in press.
4. Kato, S. The Stenosis of Cerebral Arteries and Impaired Brain Glucose Uptake by Long-Lasting Inflammatory Cytokine Release from Dermatitis Is Rescued by Anti-IL-1 Therapy. J Invest Dermatol,in press.
5. Katayama, H. An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform. Clin Appl Thromb Hemost,in press.
6. Ichikawa, A. Pyoderma gangrenosum reproduced by an electric current flow. J Dermatol.in press.
1. Yamanaka, K. Neutrophils are not the dominant interleukin-17 producer in psoriasis. J Dermatol 44(7): e170-e171.
2. Yamanaka, K. Skin inflammation leads immunoglobulin G aggregation and deposition in multiple organs. J Dermatol Sci 88(1): 146-148.
3. Yamanaka, K. Restrictive IL-10 induction by an innocuous parainfluenza virus vector ameliorates nasal allergy. J Allergy Clin Immunol 139(2): 682-686 e687.
4. Thomi, R. Increased expression of the interleukin-36 cytokines in lesions of hidradenitis suppurativa. J Eur Acad Dermatol Venereol.
5. Sekiya, A. Compound heterozygotes for filaggrin gene mutations do not always show severe atopic dermatitis. J Eur Acad Dermatol Venereol 31(1): 158-162.
6. Okada, K. Well-controlled juvenile dermatomyositis over 20 years recurred after delivery. J Dermatol 44(7): 855-857.
7. Okada, K. Cutaneous polyarteritis nodosa causing refractory skin deformation and pigmentation as sequel. An Bras Dermatol 92(5 Suppl 1): 53-55.
8. Mizutani, K. Successful combination therapy of propranolol and prednisolone for a case with congenital Kasabach-Merritt syndrome. J Dermatol 44(12): 1389-1391.
9. Kondo, M. Case with acute urticaria by red meat after Haemaphysalis longicornis bite. J Dermatol 44(7): e168-e169.
10. Kondo, M. Rickettsia species among ticks in an area of Japan endemic for Japanese spotted fever. Southeast Asian J Trop Med Public Health 48(3): 585-589.
11. Kondo, M. Case with cellulitis, lymphangitis and subcutaneous nodule suspected due to Rickettsia japonica carrying tick bite. J Dermatol 44(10): 1182-1183.
12. Kondo, M. Case of dengue fever missed at the initial screening of an endemic area but developed later in Japan. J Dermatol 44(7): 847-848.
13. Kamimoto, Y. Hypofibrinogenemia and the alpha-Fibrinogen Thr312Ala Polymorphism may be Risk Factors for Early Pregnancy Loss. Clin Appl Thromb Hemost 23(1): 52-57.
14. Kakeda, M. Is the Anti-NXP-2(ANTI-MJ) antibody a marker antibody for dysphagia in
dermatomyositis?-report of three cases. EMJ Dermatology 5(1): 57-58.
15. Imafuku, S. Interleukin-17-mediated manifestation of psoriasis and tinea. Australasian Journal of Dermatology, in press.
16. Habe, K. Plasma ADAMTS13, von Willebrand Factor (VWF), and VWF Propeptide Profiles in Patients With Connective Tissue Diseases and Antiphospholipid Syndrome. Clin Appl Thromb Hemost 23(6): 622-630.
17. Habe, K. The Plasma Levels of ADAMTS-13, von Willebrand Factor, VWFpp, and Fibrin-Related Markers in Patients With Systemic Sclerosis Having Thrombosis. Clin Appl Thromb Hemost: 1076029617736382.
18. Gyoubu, M. Long-lasting effect of intra-tumor administration of OK-432 against squamous cell carcinoma metastatic lesion International Journal of Advances In Case Reports.
19. Amagai, M. A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid. J Dermatol Sci 85(2): 77-84.
1. Yamanaka, K. A new biomarker for psoriasis. Br J Dermatol 174(6): 1191-1192.
2. Umaoka, A. Infantile giant molluscumcontagiosum:The importance of early intervention. International Journal of Advances In Case Reports 3(7): 94.
3. Suehara, K. Color Calibration for the Pressure Ulcer Image Acquired Under Different Illumination:A Key Step for Simple,Rapid and Quantitative Color Evaluation of the Human Skin Diseases Using a Digital Camera. Journal of Light&Visual Environment 40: 10-19.
4. Mitani, O. Enhanced wound healing by topical application of ointment containing a low concentration of povidone-iodine. J Wound Care 25(9): 521-529.
5. Kondo, M. Nodules behind the ears: IgG4-related skin disease. Br J Dermatol 175(5): 1056-1058.
6. Kondo, M. A case series of mamushi bite and adverse effects of antiserum injection in several cases. Int J Adv Med 3: 1065-1067.
7. Kondo, M. First case of redness and erosion at bacillus Calmette-Guerin inoculation site after vaccination against influenza. J Dermatol 43(10): 1229-1231.
8. Kondo, M. Case of lumbar disc hernia caused in the left L4 and L5 dermatomes after herpes zoster infection in the right L2 and L3 dermatomes. Journal of Dermatology 43(8): 977-978.
9. Kondo, M. Two Japanese siblings affected with Chikungunya fever with different clinical courses: Imported infections from the Cook Islands. J Dermatol 43(6): 697-700.
10. Higashiyama, A. Flutamide-induced photoleukomelanoderma. J Dermatol 43(9): 1105-1106.
11. Habe, K. Presence of Antiphospholipid Antibodies as a Risk Factor for Thrombotic Events in Patients with Connective Tissue Diseases and Idiopathic Thrombocytopenic Purpura. Intern Med 55(6): 589-595.
12. Chalmers, J. R. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative). Br J Dermatol 175(1): 69-79.
1. Yamanaka, K. Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen. Allergol Int 64(1): 54-59.
2. Yamanaka, K. Pyoderma gangrenosum and annular erythema associated with Sjogren's syndrome controlled with minocycline. J Dermatol 42(8): 834-836.
3. Yamanaka, K. Olopatadine, a non-sedating H1 antihistamine, decreases the nocturnal scratching without affecting sleep quality in atopic dermatitis. Exp Dermatol 24(3): 227-229.
4. Yamanaka, K. "Inflammatory skin march": IL-1-mediated skin inflammation, atopic dermatitis, and psoriasis to cardiovascular events. J Allergy Clin Immunol 136(3): 823-824.
5. Yamanaka, K. Band-like lipoatrophy on the forearm by injected triamcinolone acetonide to wrist joint. J Dermatol 42(9): 934-935.
6. Sasoh, M. Incidence of retinal detachment associated with atopic dermatitis in Japan: review of cases from 1992 to 2011. Clin Ophthalmol 9(9): 1129-1134.
Matthews, A. G. Compound heterozygous mutation of Rag1 leading to Omenn syndrome. PLoS One 10(4): e0121489.
7. Kondo, M. A first report of rickettsia japonica detected from amblyomma testudinarium. International Journal Of Advances In Case Reports 2(21): 1268-1270.
8. Kondo, M. Improvement in early diagnosis of Japanese spotted fever by using a novel Rick PCR system. J Dermatol 42(11): 1066-1071.
9. Kondo, M. Biting by ticks carrying rickettsia tamurae is not always risk for rickettsia disease in an immunocompetent subject. International Journal of Advances In Case Reports 2(21): 1271-1273.
10. Kido-Nakahara, M. Comparative cut-off value setting of pruritus intensity in visual analogue scale and verbal rating scale. Acta Derm Venereol 95(3): 345-346.
11. Isoda, K. Effects of washing of the face with a mild facial cleanser formulated with sodium laureth carboxylate and alkyl carboxylates on acne in Japanese adult males. Skin Res Technol 21(2): 247-253.
12. Isoda, K. Efficacy of the combined use of a facial cleanser and moisturizers for the care of mild acne patients with sensitive skin. J Dermatol 42(2): 181-188.
1. Yamanaka, K. Biologic therapy improves psoriasis by decreasing the activity of monocytes and neutrophils. J Dermatol 41(8): 679-685.
2. Yamanaka, K. Continuous high-dose antigen exposure preferentially induces IL-10, but intermittent antigen exposure induces IL-4. Exp Dermatol 23(1): 63-65.
3. Yamanaka, K. Persistent release of IL-1s from skin is associated with systemic cardio-vascular disease, emaciation and systemic amyloidosis: the potential of anti-IL-1 therapy for systemic inflammatory diseases. PLoS One 9(8): e104479.
4. Takagi, Y. A new formula for a mild body cleanser: sodium laureth sulphate supplemented with sodium laureth carboxylate and lauryl glucoside. Int J Cosmet Sci 36(4): 305-311.
5. Noro, Y. Novel acoustic evaluation system for scratching behavior in itching dermatitis: rapid and accurate analysis for nocturnal scratching of atopic dermatitis patients. J Dermatol 41(3): 233-238.
6. Nigi, Y. Pyoderma gangrenosum with corneal perforation by Mooren's ulcer. J Dermatol 41(5): 466-467.
7. Kakeda, M. Innate immune cells express IL-17A/F in acute generalized exanthematous pustulosis and generalized pustular psoriasis. Arch Dermatol Res 306(10): 933-938.
8. Kakeda, M. Increased expression of heat shock protein 90 in keratinocytes and mast cells in patients with psoriasis. J Am Acad Dermatol 70(4): 683-690 e681.
9. Dohi, K. Arrhythmogenic right ventricular cardiomyopathy in a 20-year-old woman with systemic sclerosis. Intern Med 53(9): 973-977.
10. Chalmers, J. R. Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME). Br J Dermatol 171(6): 1318-1325.
11. Brzezinski, P. DERMATOLOGY EPONYMS-SIGN-LEXICON-(M). Our Dermatol Online3 5(3).
12. Akeda, T. CD8+ T cell granzyme B activates keratinocyte endogenous IL-18. Arch Dermatol Res 306(2): 125-130.
1. Sugiura, K. The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist. J Invest Dermatol 133(11): 2514-2521.
2. Nakanishi, T. Mutant interleukin-4/13 signaling blockade successfully suppresses acute phase inflammation. Arch Dermatol Res 305(3): 241-247.
3. Lee, H. Y. Cytokines and chemokines in irritant contact dermatitis. Mediators Inflamm 2013: 916497.
4. Kitagawa, H. Intranasally administered antigen 85B gene vaccine in non-replicating human Parainfluenza type 2 virus vector ameliorates mouse atopic dermatitis. PLoS One 8(7): e66614.
5. Imai, Y. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proceedings of the National Academy of Sciences of the United States of America 110(34): 13921-13926.
6. Habe, K. Presence of antiphospholipid antibody is a risk factor in thrombotic events in patients with antiphospholipid syndrome or relevant diseases. Int J Hematol 97(3): 345-350.
7. Habe, K. Two patients with antiphospholipid antibody developed disseminated intravascular coagulation. Intern Med 52(2): 269-272.
1. Yuta A. Therapeutic outcomes and immunological effects of sublingual immunotherapy for Japanese cedar pollinosis Clinical & Experimental Allergy Reviews 12: 29-35.
2. Tsuda, K. Ustekinumab improves psoriasis without altering T cell cytokine production, differentiation, and T cell receptor repertoire diversity. PLoS One 7(12): e51819.
3. Tsuda, K. Calcineurin inhibitors suppress cytokine production from memory T cells and differentiation of naive T cells into cytokine-producing mature T cells. PLoS One 7(2): e31465.
4. Nakamori, R. Complete remission of advanced extramammary Paget's disease treated with docetaxel: a case report. Clin Exp Dermatol 37(2): 194-195.
5. Mizutani, H. Single step modified ink staining for Tzanck test: quick detection of herpetic giant cells in Tzanck smear. J Dermatol 39(2): 138-140.
6. Konishi, Y. Treatment of vitiligo vulgaris with the combination therapy of topical steroid and vitamin D3 compound. Dermatol Reports 4(1): e8.
7. Kakeda, M. Heat-killed bacillus Calmette-Guerin and Mycobacterium kansasii antigen 85B combined vaccination ameliorates dermatitis in a mouse model of atopic dermatitis by inducing regulatory T cells. Br J Dermatol 166(5): 953-963.
8. Habe, K. Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases. Thromb Res 129(5): 598-602.
9. Akeda, T. Intratumoral injection of OK-432 suppresses metastatic squamous cell carcinoma lesion inducing interferon-gamma and tumour necrosis factor-alpha. Clin Exp Dermatol 37(2): 193-194.
1. Yamanaka, K. SLIT improves cedar pollinosis by restoring IL-10 production from Tr1 and Monocytes approximately IL-10 productivity is critical for becoming allergic approximately. Allergol Int 60(1): 45-51.
2. Yamanaka, K. The role of cytokines/chemokines in the pathogenesis of atopic dermatitis. Curr Probl Dermatol 41: 80-92.
3. Tsutsui, H. Contribution of interleukin 18 to the development of infection-associated atopic dermatitis. Curr Probl Dermatol 41: 93-103.
4. Tsuda, K. Intratumoral injection of Propionibacterium acnes suppresses malignant melanoma by enhancing Th1 immune responses. PLoS One 6(12): e29020.
5. Oiso, N. The histopathological feature of the nail isthmus in an ectopic nail. Am J Dermatopathol 33(8): 841-844.
6. Kurokawa, I. Keratin and filaggrin expression in comedonal Darier's disease. J Dermatol 38(11): 1089-1092.
7. Kurokawa, I. Expression of keratins in cutaneous epithelial tumors and related disorders- distribution and clinical significance. Exp Dermatol 20(3): 217-228.
8. Kondo, M. Sarcoidosis with both plaque and subucutaneus nodules associated with combination therapy with peginterferon α-2a and ribavirin. Case reports in Dermatological Medicine
9. Kitagawa, H. Propionibacterium acnes vaccination induces regulatory T cells and Th1 immune responses and improves mouse atopic dermatitis. Exp Dermatol 20(2): 157-158.
10. Isoda, K. Treatment of cloth with a fabric softener ameliorates skin dryness. J Dermatol 38(7): 685-692.
11. Clark, R. A. High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma. Blood 117(6): 1966-1976.
1. Yoshida, M. A Case of Multiple Pilosebaceous Cysts. Case Rep Dermatol 2(2): 116-119.
2. Yamanaka, K. I. 1,24-Dihydroxyvitamin D(3) (tacalcitol) prevents skin T-cell infiltration. Br J Dermatol 162(6): 1206-1215.
3. Yamanaka, K. Restoration of peripheral blood T cell repertoire complexity during remission in advanced cutaneous T cell lymphoma. Arch Dermatol Res 302(6): 453-459.
4. Tsuruta, D. Letter: Adult measles with a butterfly rash-like appearance. Dermatol Online J 16(3): 16.
5. Tsuruta, D. Three-base deletion mutation c.120_122delGTT in ATP2A2 leads to the unique phenotype of comedonal Darier disease. Br J Dermatol 162(3): 687-689.
6. Tsuji, N. Epidermal cyst with pilomatricoma (follicular hybrid cyst): immunohistochemical study with epithelial keratins and filaggrin. J Dermatol 37(10): 922-925.
7. Senba, Y. Primary cutaneous apocrine carcinoma arising within a congenital nevus: Keratins and filaggrin expression suggesting differentiation into the secretory cells of apocrine glands. Oncology Letters 1(3): 413-416.
8. Omoto, Y. Granzyme B is a novel interleukin-18 converting enzyme. J Dermatol Sci 59(2): 129-135.
9. Kurokawa, I. Immunohistochemical study of cytokeratin expression in nevus sebaceous. Int J Dermatol 49(4): 402-405.
10. Konishi, H. Possible case for false-positive reaction in serum 5-S-cysteinyldopa levels in a patient with malignant melanoma by ingestion of Agaricus blazei Murrill extract. J Dermatol 37(8): 773-775.
11. Kondo, M. Nine cases of Japan spotted fever diagnosed at our hospital in 2008. International Journal of Dermatology 49(4): 430-434.
12. Kondo, M. Topical treatment with incision and antiseptic may prevent the severity of Japan spotted fever. Journal of Dermatology 37(9): 835-836.
13. Kondo, M. Japanese spotted fever with acute hepatic failure: was it associated with Epstein-Barr virus? Int J Dermatol 49(12): 1403-1405.
1. Yamanaka, K. Induction of IL-10-producing regulatory T cells with TCR diversity by epitope-specific immunotherapy in pollinosis. J Allergy Clin Immunol 124(4): 842-845 e847.
2. Sugisaki, H. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease. J Dermatol Sci 55(1): 47-52.
3. Senba, Y. Case of creeping disease treated with ivermectin. J Dermatol 36(2): 86-89.
4. Senba, Y. Folliculosebaceous cystic hamartoma differentiates toward the infundibulum, sebaceous duct and sebaceous cells: immunohistochemical study of keratins and filaggrin. Br J Dermatol 160(2): 454-456.
5. Morioka, T. IL-4/IL-13 antagonist DNA vaccination successfully suppresses Th2 type chronic dermatitis. Br J Dermatol 160(6): 1172-1179.
6. Morioka, T. A case of beau's lines at even intervals and onycholysis caused by chemotherapy. The Open Dermatology Journal 3(1): 16-17.
7. Mori, H. Administration of Ag85B showed therapeutic effects to Th2-type cytokine-mediated acute phase atopic dermatitis by inducing regulatory T cells. Archives of Dermatological Research 301(2): 151-157.
8. Kurokawa, I. Pilomatricoma can differentiate not only towards hair matrix and hair cortex,but also follicular infundibulum,outer root sheath and hair bulge. Experimental Dermatology 18(8): 734-737.
9. Kurokawa, I. New developments in our understanding of acne pathogenesis and treatment. Experimental Dermatology 18(10): 821-832.
10. Kondo, M. Leg ulcer caused by Mycobacterium ulcerans ssp. shinshuense infection. Int J Dermatol 48(12): 1330-1333.
11. Iinuma, K. Involvement of Propionibacterium acnes in the augmentation of lipogenesis in hamster sebaceous glands in vivo and in vitro. J Invest Dermatol 129(9): 2113-2119.
12. Fujimoto, T. Cutaneous malignant fibrous histiocytoma (undifferentiated pleomorphic sarcoma) arising in a chronic scalp ulcer of a patient with non-bullous congenital ichthyosiform erythroderma. J Eur Acad Dermatol Venereol 23(2): 202-203.
1. Yamanaka, K. Vitamins A and D are potent inhibitors of cutaneous lymphocyte-associated antigen expression. J Allergy Clin Immunol 121(1): 148-157 e143.
2. Tsuda, T. A novel point mutation of keratin 17 (KRT17) in a Japanese family with pachyonychia congenita type 2: an RNA-based genetic analysis using a single hair bulb. British Journal of Dermatology 159(3): 730-732.
3. Tsuda, T. Effect of 14-membered-ring macrolides on production of interleukin-8 mediated by protease-activated receptor 2 in human keratinocytes. Antimicrob Agents Chemother 52(4): 1538-1541.
4. Tokime, K. Enhanced production and secretion of glial cell line-derived neurotrophic factor and nerve growth factor from the skin in atopic dermatitis mouse model. Arch Dermatol Res 300(7): 343-352.
5. Takagi, E. Clinical and histopathological features in Henoch-Schonlein purpura. Int J Dermatol 47(1): 48-49.
6. Sugimura, Y. Identification of preferred substrate sequences for transglutaminase 1-development of a novel peptide that can efficiently detect cross-linking enzyme activity in the skin. Febs Journal 275(22): 5667-5677.
7. Nakaminami, H. Characterization of the pTZ2162 encoding multidrug efflux gene qacB from Staphylococcus aureus. Plasmid 60(2): 108-117.
8. Nakagawa, N. Adult cutaneous alveolar rhabdomyosarcoma on the face diagnosed by the expression of PAX3-FKHR gene fusion transcripts. J Dermatol 35(7): 462-467.
9. Kurzen, H. What causes hidradenitis suppurativa? Experimental Dermatology 17(5): 455-472.
10. Kakudo, N. Dumbbell-formed lipomas under the zygomatic arch. J Plast Reconstr Aesthet Surg 61(1): 107-110.
11. Ito, Y. Necrobiotic xanthogranuloma with paraproteinemia; an atypical case. J Dtsch Dermatol Ges 6(1): 40-43.
12. Ito, Y. Keratin and filaggrin expression in keratoacanthoma. J Eur Acad Dermatol Venereol 22(3): 353-355.
13. Ito, Y. Guinea pig cysteinyl leukotriene receptor 2 (gpCysLT2) mediates cell proliferation and intracellular calcium mobilization by LTC4 and LTD4. BMB Rep 41(2): 139-145.
14. Imai, Y. Freshly isolated Langerhans cells negatively regulate naive T cell activation in response to peptide antigen through cell-to-cell contact. J Dermatol Sci 51(1): 19-29.
1. Yokoyama, T. Pilonidal sinus of the supra-auricle area. J Eur Acad Dermatol Venereol 21(2): 257-258.
2. Shima, S. A case of Admantiades-Behcet disease with ischemic optic neuritis (posterior optic neuropathy). JDDG 5: 1010-1014.
3. Nakaminami, H. Transduction of the plasmid encoding antiseptic resistance gene qacB in Staphylococcus aureus. Biol Pharm Bull 30(8): 1412-1415.
4. Kurokawa, I. Pinkus tumor may originate from intraepidermal eccrine ducts and proliferate in the dermis. Oncology Reports 17(1): 49-54.
5. Kurokawa, I. Filaggrin expression and the pathogenesis of epidermal cysts. Br J Dermatol 157(2): 415-416.
6. Kurokawa, I. Cytokeratin expression in squamous cell carcinoma arising from hidradenitis suppurativa (acne inversa). J Cutan Pathol 34(9): 675-678.
7. Kurokawa, I. Eccrine spiradenoma: co-expression of cytokeratin and smooth muscle actin suggesting differentiation toward myoepithelial cells. J Eur Acad Dermatol Venereol 21(1): 121-123.
8. Kurokawa, I. Rippled-pattern sebaceoma with an immunohistochemical study of cytokeratins. J Eur Acad Dermatol Venereol 21(1): 133-134.
9. Kurokawa, I. Cytokeratin and filaggrin expression in nevus comedonicus. J Cutan Pathol 34(4): 338-341.
10. Kurokawa, I. The change in zoster-associated pain treated with oral valaciclovir in immunocompetent patients with acute herpes zoster. Int J Clin Pract 61(7): 1223-1229.
11. Kitagawa, H. Cutaneous horn can be a clinical manifestation of underlying sebaceous carcinoma. British Journal of Dermatology 156(1): 180-182.
12. Ito, Y. Magnetic resonance (MR) imaging-induced deep second-degree burns of lower extremities by conducting loop. J Eur Acad Dermatol Venereol 21(8): 1140-1141.
1. Yamanaka, K. Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma. Blood 107(6): 2440-2445.
2. Yamanaka, K. Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma. Clin Cancer Res 12(2): 376-382.
3. Umeda, K. A novel acoustic evaluation system of scratching in mouse dermatitis: rapid and specific detection of invisibly rapid scratch in an atopic dermatitis model mouse. Life Sci 79(22): 2144-2150.
4. Terada, M. Contribution of IL-18 to atopic-dermatitis-like skin inflammation induced by Staphylococcus aureus product in mice. Proc Natl Acad Sci U S A 103(23): 8816-8821.
5. Omoto, Y. Human mast cell chymase cleaves pro-IL-18 and generates a novel and biologically active IL-18 fragment. J Immunol 177(12): 8315-8319.
6. Noguchi, N. Antimicrobial agent of susceptibilities and antiseptic resistance gene distribution among methicillin-resistant Staphylococcus aureus isolates from patients with impetigo and staphylococcal scalded skin syndrome. J Clin Microbiol 44(6): 2119-2125.
7. Nishimura, K. Reduced Heterochromatin protein 1-beta(HP1É¿) expression is correlated with increased invasive activity in human melanoma cells. ANTICANCER RESEARCH 26: 4349-4356.
8. Murakami, T. Topical suplatast tosilateÅiIPDÅjameliorates Th2 cytokine-mediated dermatitis of caspase-1 transgenic mouse by downregulating interleukin-4 and interleukin-5. British Journal Dermatol 155(1): 27-32.
9. Kurokawa, I. Keratin profiles may differ between intraepidermal and intradermal invasive eccrine porocarcinoma. Oncol Rep 16(3): 473-478.
10. Kurokawa, I. Cytokeratin expression in trichilemmal carcinoma suggests differentiation towards follicular infundibulum. In Vivo 20(5): 583-585.
11. Kurokawa, I. Cytokeratin expression in subungual squamous cell carcinoma. J Int Med Res 34(4): 441-443.
12. Kurokawa, I. Cutaneous dermoid cyst: cytokeratin and filaggrin expression suggesting differentiation towards follicular infundibulum and mature sebaceous gland. Oncol Rep 16(2): 295-299.
13. Kurokawa, I. Cytokeratin, filaggrin, and p63 expression in reepithelialization during human cutaneous wound healing. Wound Repair Regen 14(1): 38-45.
14. Hirahara, K. The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors. J Immunol 177(7): 4488-4494.
15. Clark, R. A. A novel method for the isolation of skin resident T cells from normal and diseased human skin. J Invest Dermatol 126(5): 1059-1070.
16. Clark, R. A. The vast majority of CLA+ T cells are resident in normal skin. J Immunol 176(7): 4431-4439.
1. Yokoyama, T. Aurora-B and Rho-kinase/Rock,the two cleavage furrow kinases,independently regulate the progression of cytokinesis:Possible existence of a novel cleavage furrow kinase phosphorylates ezrin/radixin/moesin(ERM). Genes Cells 10(2): 127-137.
2. Yamanaka, K. Basic fibroblast growth factor treatment for skin ulceration associated with systemic sclerosis dominant overlap syndrome. Cutis.
3. Yamaguchi, T. Phosphorylation by Cdk1 induces Plk1-mediated vimentin phosphorylation during mitosis. J Cell Biol 171(3): 431-436.
4. Shen, C. The Expression of p63 during Epidermal Remodeling in Psoriasis. Journal of Dermatology 32(4): 236-242.
5. Nomura, E. Extra Nodal NK/T-Cell Lymphoma Nasal Type that Responded to DeVIC Combination Chemotherapy. Journal of Dermatology 32(3): 204-209.
6. Nishizawa, M. Identification of Trichoplein,a novel keratin filament-binding protein. Journal of Cell Science 118(5): 1081-1090.
7. Nakanishi, A. Atelocollagen sponge and recombinant basic fibroblast growth factor combination therapy for resistant wounds with deep cavities. The Journal of Dermatology 32(5): 376-380.
8. Mori, H. Relapse of dermatomyositis after 10 years in remission following curative surgical treatment of lung cancer. J Dermatol 32(4): 290-294.
9. Kurokawa, I. Lichen planus-type drug eruption resulting from ticlopidine. Int J Dermatol 44(5): 436-437.
10. Kurokawa, I. Exacerbation of palmoplantar pustulosis by granulocyte colony-stimulating factor. Int J Dermatol 44(6): 529-530.
11. Kurokawa, I. Vesicular drug eruption due to Stronger Neo-minophagen C. Int J Dermatol 44(10): 881-882.
12. Kurokawa, I. A case report of hidroacanthoma simplex with an immnnohistochemical study of cytokeratins. Int J Dermatol 44(9): 775-776.
13. Kurokawa, I. Keratinizing squamous epithelium associated with Syringocystoadenoma papilliferum differentiates towards infrainfundibulum: case report with immunohistochemical study of cytokeratins. The Journal of International Medical Research 33: 590-593.
14. Kurokawa, I. Trichoadenoma:cytokeratin expression suggesting differentiation towards the follicular infundibulum and follicular bulge regions. British Journal of Dermatology 153(5): 1084-1086.
15. Kurokawa, I. Purpuric drug eruption possibly due to gefinitib(Iressa). Int J Dermatol 44(2): 167-168.
16. Kupper, T. S. Expression of interleukin-18 and caspase-1 in cutaneous T cell lymphoma. Journal of Investigative Dermatology 124(4): A47-A47.
17. Kakeda, M. A Case of Histopathologically Typical Toxic Epidermal Necrolysis Despite No Visible Blisters or Erosive Lesions. Journal of Dermatology 32(8): 654-660.
18. Jones, D. Activation of neutrophils in cutaneous T cell lymphoma. Clin Cancer Res.
19. Ishii, A. A Case of epidermotropic metastatic malignant melanoma with multiple nodular lesions of the scalp. The Journal of Dermatology 32(10): 821-826.
20. Inaba, T. Complete remission in a patient with angiosarcoma by the combination of OK-432,rhIL-2,and radiotherapy. Eur J Dermatol 15(5): 411-413.
21. Clark, R. Human skin cells support thymus-independent T cell development. J Clin Inves 115(11): 3239.
1. Yamanishi, Y. Apoptopsis in the Epidermis. Molecular Biology 289: 171-174.
2. Umehara, M. Disseminated maculo-papular erythematous-type drug eruption due to tipepidine hibenzate. Skin Research 4(2): 121.
3. Umehara, M. Primary cutaneous anaplastic large cell lymphoma successfully treated by resective operation and postoperative electron-beam therapy. Skin Research 3(5): 493.
4. Tsutsui, H. Induction of allergic inflammation by interleukin-18 in experimental animal models. Immunological Reviews 202: 115-138.
5. Mori, H. Drug Eruption Caused by Azathioprine:Value of Using the Drug-Induced Lymphocytes Stimulation Test for Diagnosis. Journal of Dermatolory 31(9): 731-736.
6. Mizutani, H. Animal Models of Atopic Dermatitis. 47 11: 501-507.
7. Imai, Y. A Case of a Large Dermatofibrosarcoma Protuberans Successfully
Treated with Radiofrequency Ablation and Transcatheter Arterial
Embolization. Journal of Dermatology 31(1): 42-46.
1. Yawalkar, N. Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma. Blood 102(12): 4059-4066.
2. Nakano, H. Persistent secretion of IL-18 in the skin contributes to IgE response in mice. Int Immunol 15: 611-621.
3. Mizutani, H. Animal models of psoriasis and pustular psoriasis. Arch Dermtol Res 295: S67-S68.
4. Matsushima, M. Bilateral Scalp Necrosis with Giant Cell Arteritis. Journal of Dermatology 30(3): 210-215.
5. Imai, Y. Primary Cutaneous Follicle Cencer Cell Lymphoma of the Scalp Successfully Treated with Anti CD20 Monoclonal Antibody and CHOP Combination Therapy with No Subsequent Permanent Loss of Hair. Journal of Dermatology 30(9): 683-688.
1. Matsubara, K. Pyoderma gangrenosum associated with paroxysmal nocturnal hemoglobulinuria and monoclonal gammopathy. J Dermatol 29(2): 86-90.
2. Konishi, H. IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc Natl Acad Sci U S A 99(17): 11340-11345.
1. Sayama, K. Apoptosis signal-regulating kinase 1 (ASK1) is an intracellular inducer of keratinocyte differentiation. Journal of Biological Chemistry 276(2): 999-1004.
1. Yoshimoto, T. IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6. Nat Immunol 1(2): 132-137.
2. Yamanaka, K. Skin-specific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18. Journal of Immunology 165(2): 997-1003.
3. Tokime, K. A case of acute graft-versus-host disease following autologous peripheral blood stem cell transplantation. J Dermatol 27(7): 446-449.
Onoda, K. Atopic dermatitis as a risk factor for acute native valve endocarditis. Journal of Heart Valve Disease 9(3): 469-471.
4. Mizutani, H. Cassiopeia flap: modification of Limberg flap for saving normal skin. J Dermatol 27(3): 217-219.